Amicus Therapeutics: Q2 Earnings Snapshot

PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Amicus Therapeutics Inc. (FOLD) on Thursday reported a loss of $15.7 million in its second quarter.

The Princeton, New Jersey-based company said it had a loss of 5 cents per share. Earnings, adjusted for stock option expense and pretax expenses, came to 6 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 3 cents per share.

The pharmaceutical company posted revenue of $126.7 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $120.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up